Clinical Trial

Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)

Study acronym: ANDROLIPO
Recruiting
View on ClinicalTrials.gov →
Summary
Diagnostic case-control study (1 case for 2 controls). Inclusion of patients with severe insulin resistance syndrome of genetic origin, then inclusion of controls: patients examined for PCOS in day hospital with matching age (+/- 5 years) and Body mass index (+/- 5kg/m2).
Protocol Amendment History 3 changes
critical Recruitment opened 2026-08-11
notable Primary completion pushed: 2027-09 -> 2028-01 2026-08-11
minor Completion pushed: 2027-09 -> 2028-01 2026-08-11
Trial Details
NCT Number NCT07412028
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Polycystic Ovary Syndrome, Familial Partial Lipodystrophy, LMNA (LaMin Nuclear A) Related Disorders
Enrollment 81 participants
Start Date 2026-07-21
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-10